F.L. Putnam Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8M | Buy |
37,741
+1,245
| +3% | +$554K | 0.29% | 69 |
|
|
2025
Q1 | $17.7M | Buy |
36,496
+5,053
| +16% | +$2.45M | 0.33% | 65 |
|
|
2024
Q4 | $12.7M | Buy |
31,443
+22,141
| +238% | +$8.92M | 0.23% | 86 |
|
|
2024
Q3 | $4.33M | Buy |
9,302
+7,589
| +443% | +$3.53M | 0.08% | 176 |
|
|
2024
Q2 | $803K | Buy |
1,713
+267
| +18% | +$125K | 0.02% | 348 |
|
|
2024
Q1 | $604K | Buy |
1,446
+66
| +5% | +$27.6K | 0.01% | 313 |
|
|
2023
Q4 | $562K | Buy |
1,380
+16
| +1% | +$6.51K | 0.01% | 318 |
|
|
2023
Q3 | $474K | Buy |
1,364
+10
| +0.7% | +$3.48K | 0.01% | 343 |
|
|
2023
Q2 | $476K | Buy |
1,354
+149
| +12% | +$52.4K | 0.01% | 357 |
|
|
2023
Q1 | $380K | Buy |
1,205
+128
| +12% | +$40.3K | 0.01% | 336 |
|
|
2022
Q4 | $311K | Buy |
1,077
+150
| +16% | +$43.3K | 0.01% | 343 |
|
|
2022
Q3 | $268K | Sell |
927
-26
| -3% | -$7.52K | 0.01% | 350 |
|
|
2022
Q2 | $269K | Sell |
953
-7
| -0.7% | -$1.98K | 0.01% | 353 |
|
|
2022
Q1 | $251K | Buy |
960
+23
| +2% | +$6.01K | 0.01% | 369 |
|
|
2021
Q4 | $206K | Buy |
+937
| New | +$206K | 0.01% | 397 |
|
|
2021
Q2 | – | Sell |
-949
| Closed | -$204K | – | 417 |
|
|
2021
Q1 | $204K | Sell |
949
-63
| -6% | -$13.5K | 0.01% | 355 |
|
|
2020
Q4 | $239K | Sell |
1,012
-17
| -2% | -$4.02K | 0.01% | 296 |
|
|
2020
Q3 | $280K | Hold |
1,029
| – | – | 0.02% | 251 |
|
|
2020
Q2 | $299K | Buy |
1,029
+1
| +0.1% | +$291 | 0.02% | 253 |
|
|
2020
Q1 | $245K | Buy |
+1,028
| New | +$245K | 0.02% | 250 |
|